James Tumlin, MD
NephroNet, Inc. · Georgia Nephrology Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Tumlin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:10 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07225387 · Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy TrialNephroNet, Inc. · recruiting · Lupus Nephritis · principal investigator
- Ph2NCT05709444 · A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney DiseasePalatin Technologies, Inc · completed · Kidney Disease · principal investigator
- Ph4NCT05546047 · A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy PatientsNephroNet, Inc. · unknown · Fibrillary Glomerulonephritis · principal investigator
- Ph4NCT05535920 · A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic HyperkalemiaNephroNet, Inc. · completed · Hyperkalemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.